VEGF distribution in proliferative diabetic retinopathy

D. Foreman, G. Williams, M. E. Boulton, D. McLeod

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose. To determine the staining pattern of VEGF at different stages of diabetic retinopathy. Method. Immunohistochemical localisation of VEGF, using an antibody raised against the 165 amino acid form of human VEGF, was carried out on specimens of normal human retina (n=15), diabetic retinas a) with no overt retinopathy (n=25) b) with active proliferative retinopathy (n=5), c) which had undergone successful photocoagulation therapy (n=12), and surgically resected PDR preretinal membranes (n=19). The degree and pattern of positive immunostaining was recorded. Results. VEGF staining was absent from the majority of normal retinas, with weak staining of endothelial cells of retinal vessels in 7/15 specimens. Immunostaining for VEGF was markedly increased in the majority of diabetic retinas with no overt retinopathy (20/25), especially in the thickened basement membranes of the retinal vessels (15/25). In all retinas with active neovascularisation immunostaining was intense, especially associated with intraretinal vessels adjacent to areas of active preretinal neovascularisation (5/5). Interestingly, VEGF-positive inner retinal vessels were found in less than half (5/12) of the diabetic retinas that had undergone successful laser therapy i.e. those with no active neovascularisation. Furthermore, VEGF staining was intense in all excised PDR membranes. Conclusions. This study supports a role for VEGF in the aetiology of diabetic retinopathy.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996
Externally publishedYes

Fingerprint

Diabetic Retinopathy
Vascular Endothelial Growth Factor A
Retina
Retinal Vessels
Staining and Labeling
Membranes
Light Coagulation
Laser Therapy
Basement Membrane
Endothelial Cells
Amino Acids
Antibodies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Foreman, D., Williams, G., Boulton, M. E., & McLeod, D. (1996). VEGF distribution in proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science, 37(3).

VEGF distribution in proliferative diabetic retinopathy. / Foreman, D.; Williams, G.; Boulton, M. E.; McLeod, D.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Foreman, D, Williams, G, Boulton, ME & McLeod, D 1996, 'VEGF distribution in proliferative diabetic retinopathy', Investigative Ophthalmology and Visual Science, vol. 37, no. 3.
Foreman, D. ; Williams, G. ; Boulton, M. E. ; McLeod, D. / VEGF distribution in proliferative diabetic retinopathy. In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{68e0a4355ecd44ef9ecc61ae25165965,
title = "VEGF distribution in proliferative diabetic retinopathy",
abstract = "Purpose. To determine the staining pattern of VEGF at different stages of diabetic retinopathy. Method. Immunohistochemical localisation of VEGF, using an antibody raised against the 165 amino acid form of human VEGF, was carried out on specimens of normal human retina (n=15), diabetic retinas a) with no overt retinopathy (n=25) b) with active proliferative retinopathy (n=5), c) which had undergone successful photocoagulation therapy (n=12), and surgically resected PDR preretinal membranes (n=19). The degree and pattern of positive immunostaining was recorded. Results. VEGF staining was absent from the majority of normal retinas, with weak staining of endothelial cells of retinal vessels in 7/15 specimens. Immunostaining for VEGF was markedly increased in the majority of diabetic retinas with no overt retinopathy (20/25), especially in the thickened basement membranes of the retinal vessels (15/25). In all retinas with active neovascularisation immunostaining was intense, especially associated with intraretinal vessels adjacent to areas of active preretinal neovascularisation (5/5). Interestingly, VEGF-positive inner retinal vessels were found in less than half (5/12) of the diabetic retinas that had undergone successful laser therapy i.e. those with no active neovascularisation. Furthermore, VEGF staining was intense in all excised PDR membranes. Conclusions. This study supports a role for VEGF in the aetiology of diabetic retinopathy.",
author = "D. Foreman and G. Williams and Boulton, {M. E.} and D. McLeod",
year = "1996",
month = "2",
day = "15",
language = "English (US)",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - VEGF distribution in proliferative diabetic retinopathy

AU - Foreman, D.

AU - Williams, G.

AU - Boulton, M. E.

AU - McLeod, D.

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. To determine the staining pattern of VEGF at different stages of diabetic retinopathy. Method. Immunohistochemical localisation of VEGF, using an antibody raised against the 165 amino acid form of human VEGF, was carried out on specimens of normal human retina (n=15), diabetic retinas a) with no overt retinopathy (n=25) b) with active proliferative retinopathy (n=5), c) which had undergone successful photocoagulation therapy (n=12), and surgically resected PDR preretinal membranes (n=19). The degree and pattern of positive immunostaining was recorded. Results. VEGF staining was absent from the majority of normal retinas, with weak staining of endothelial cells of retinal vessels in 7/15 specimens. Immunostaining for VEGF was markedly increased in the majority of diabetic retinas with no overt retinopathy (20/25), especially in the thickened basement membranes of the retinal vessels (15/25). In all retinas with active neovascularisation immunostaining was intense, especially associated with intraretinal vessels adjacent to areas of active preretinal neovascularisation (5/5). Interestingly, VEGF-positive inner retinal vessels were found in less than half (5/12) of the diabetic retinas that had undergone successful laser therapy i.e. those with no active neovascularisation. Furthermore, VEGF staining was intense in all excised PDR membranes. Conclusions. This study supports a role for VEGF in the aetiology of diabetic retinopathy.

AB - Purpose. To determine the staining pattern of VEGF at different stages of diabetic retinopathy. Method. Immunohistochemical localisation of VEGF, using an antibody raised against the 165 amino acid form of human VEGF, was carried out on specimens of normal human retina (n=15), diabetic retinas a) with no overt retinopathy (n=25) b) with active proliferative retinopathy (n=5), c) which had undergone successful photocoagulation therapy (n=12), and surgically resected PDR preretinal membranes (n=19). The degree and pattern of positive immunostaining was recorded. Results. VEGF staining was absent from the majority of normal retinas, with weak staining of endothelial cells of retinal vessels in 7/15 specimens. Immunostaining for VEGF was markedly increased in the majority of diabetic retinas with no overt retinopathy (20/25), especially in the thickened basement membranes of the retinal vessels (15/25). In all retinas with active neovascularisation immunostaining was intense, especially associated with intraretinal vessels adjacent to areas of active preretinal neovascularisation (5/5). Interestingly, VEGF-positive inner retinal vessels were found in less than half (5/12) of the diabetic retinas that had undergone successful laser therapy i.e. those with no active neovascularisation. Furthermore, VEGF staining was intense in all excised PDR membranes. Conclusions. This study supports a role for VEGF in the aetiology of diabetic retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=33750156550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750156550&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750156550

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -